openPR Logo
Press release

3D Cell Culture Market — Trends, Outlook,2025

11-29-2017 01:12 PM CET | Health & Medicine

Press release from: Pharamceutical

3D cell culture are biological cells that are permitted to grow in an artificially created environment in three dimensions, then they are called as 3D cell culture. It is used in drug discovery and tissue engineering due to the advantage of providing more predictive data for in vivo tests and providing more physiologically relevant information. 3D cell cultures have more stability and longer lifespan as compared to 2D cell culture system that means 3D cell cultures are more suitable for long term studies and for demonstrating long term effects of the drug. 3D cell culture systems are mostly grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. The 3D cell cultures have proven to be closer to in vivo natural system thus proving to be useful in many applications such as in cancer research. 3D cell cultures system has contributed to the various aspects of cancer biology.
Various benefits achieved through use of 3D cell culture in oncology is expected to give opportunities in therapeutic area for 3D cell culture market
Increase in incidence of various types of cancers and the need to find out an affordable and effective cure for that is the major factor driving the 3D cell culture system market. For instance, the data provided by World Health Organization (WHO) showed that in 2015, cancer caused 8.8 million of all deaths globally. The benefits achieved through use of 3D cell culture in oncology and stem cell owing to the development in 3D cell culture. The increased investment in healthcare, development of optimized 3D assays, R&D, and other research related activities are also fuelling the growth of 3D cell culture market. The 3D cultures provide next level of treatment management to patients, which will help to continue its adoption in pharmaceuticals and biotech sector and is expected to drive the growth of 3D cell culture market.

Request For Sample Copy@

Scaffold based segment holds the largest share in the 3D cell culture market
The global 3D cell culture market segments by product type, by application, by end user, and by regions
On the basis of product type,
Scaffold based platforms,Macro-Porous scaffolds,Micro porous scaffolds,Nano porous scaffolds,Scaffold free platforms,Solid scaffolds,Bioreactors,Gels,Microchips,Services
On the basis of application,
Drug Discovery,Stem cell research,Cancer research,Regenerative medicine
On the basis of end user,
Academic Institutes,Biotechnology & Pharmaceutical Companies,Contract Research Laboratories
Rise in investment by government and private companies in novel drug discovery is expected to drive the 3D cell culture market in Asia Pacific
Regional segmentation of 3D cell culture market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. Increase in focus in biotechnology industry, and rise in demand for drug discovery are the factors which expected to drive growth of the market in Asia Pacific. The rise in  government investments for  healthcare, low operating costs of industries, investments by pharmaceutical and analytical instrumental companies in 3D cell culture projects to meet the demand of novel drug discoveries and organs development are some other factors which are fuelling the growth of 3D cell culture market in this region.
Key strategies like partnership and novel concept of product are adopted by industry players in 3D cell culture market
Key players operating the 3d cell culture market includes 3D Biotek, Advanced Biomatrix, Becton and Dickinson Company (BD), corning Incorporated, Global cell solutions Inc., Thermo Fisher scientific Inc., VWR Corporation, Nanofiber solutions, Lonza Group Ltd., Synthecon incorporated, and Tecan Trading AG.  Major players in the global market are focusing on providing the product according to specific requirements of researchers. For instance, Thermo Fisher scientific has collaborated with Applikon Biotechnology and launched new single use bioreactor controller platforms-i-control and ez-control. Whereas the novel concept of customized 3D cell culture product has helped the small companies to enter in 3D cell culture industry. The strategy like agreement and partnership is also adopted by some of the key players to hold the largest market share. For instance, Lonza Group Ltd. has expanded its presence in the 3D cell culture market by signing an agreement with TAP Biosystems to distribute the RAFT 3D cell culture systems.

Get More Details On this Report:

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit our news Website:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 3D Cell Culture Market — Trends, Outlook,2025 here

News-ID: 836606 • Views: 207

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases